Last reviewed · How we verify
air cooling
At a glance
| Generic name | air cooling |
|---|---|
| Sponsor | Goldman, Butterwick, Fitzpatrick and Groff |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription (NA)
- Reshaping the Path of Vascular Cognitive Impairment (VCI) (NA)
- The Effectiveness of Emergency Room Protocols for Treating Hyperthermia (NA)
- Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis (PHASE3)
- Cooling to Alleviate Migraine #3 (NA)
- Outcomes of Pulpotomy and Root Canal Treatment in Teeth With Symptomatic Irreversible Pulpitis (NA)
- Feasibility Study for VCool™ Intranasal Cooling System in Healthy Volunteers (NA)
- Beat the Heat Boston (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- air cooling CI brief — competitive landscape report
- air cooling updates RSS · CI watch RSS
- Goldman, Butterwick, Fitzpatrick and Groff portfolio CI